Lv3
320 积分 2023-08-27 加入
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
4小时前
待确认
Functional cure based on pegylated interferon alpha therapy in nucleoside analog-suppressed HBeAg negative chronic hepatitis B: a multicenter real-world study (Everest Project in China)-3.5 years data update
21天前
已完结
A potent hepatitis B surface antigen response in subjects with inactive hepatitis B surface antigen carrier treated with pegylated‐interferon alpha
1个月前
已完结
The Rate of Spontaneous Hepatitis B Surface Antigen Seroclearance in Inactive Hepatitis B Carriers: A Study from Medium Endemic Area
1个月前
已完结
A persistently low HBV DNA level is a predictor of spontaneous HBsAg clearance in patients with chronic hepatitis B
1个月前
已关闭
Similarly low risk of hepatocellular carcinoma after either spontaneous or nucleos(t)ide analogue‐induced hepatitis B surface antigen loss
1个月前
已完结
Lifetime risk of liver‐related outcomes and determinants in male inactive carriers of chronic hepatitis B
1个月前
已完结
Quantification of hepatitis B surface antigen can help predict spontaneous hepatitis B surface antigen seroclearance
1个月前
已关闭
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection
1个月前
已完结
皖公网安备34019202002308
